Miromatrix Medical Inc. (MIRO) Financial Statements (2025 and earlier)
Company Profile
| Business Address |
6455 FLYING CLOUD DRIVE EDEN PRAIRIE, MN 55344 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2836 - Biological Products, Except Diagnostic Substances (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)Annual | Quarterly
| 9/30/2023 Q3 | 6/30/2023 Q2 | 3/31/2023 Q1 | 12/31/2022 Q4 | 9/30/2022 Q3 | 6/30/2022 Q2 | 3/31/2022 Q1 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 20,400 | 25,605 | 25,197 | 31,541 | 32,674 | 44,685 | |||
| Cash and cash equivalents | 4,572 | 13,620 | 5,208 | 5,538 | 12,593 | 44,685 | |||
| Short-term investments | 15,828 | 11,985 | 19,989 | 26,003 | 20,080 | ||||
| Restricted cash and investments | 800 | 800 | 800 | 800 | 800 | 800 | |||
| Receivables | 536 | 535 | 930 | 12 | 4 | 7 | |||
| Other undisclosed current assets | 146 | 408 | 383 | 482 | 482 | 652 | |||
| Total current assets: | 21,881 | 27,348 | 27,311 | 32,835 | 33,959 | 46,144 | |||
| Noncurrent Assets | |||||||||
| Finance lease, right-of-use asset, after accumulated amortization | 81 | 91 | 100 | ||||||
| Operating lease, right-of-use asset | 1,571 | 1,623 | 1,674 | 1,723 | 1,772 | 1,821 | |||
| Property, plant and equipment | 4,999 | 5,271 | 5,546 | 5,816 | 5,792 | 5,992 | |||
| Long-term investments and receivables | 5,939 | ||||||||
| Long-term investments | 5,939 | ||||||||
| Other undisclosed noncurrent assets | 152 | 142 | 91 | ||||||
| Total noncurrent assets: | 6,570 | 6,894 | 7,452 | 7,772 | 13,695 | 7,813 | |||
| TOTAL ASSETS: | 28,451 | 34,242 | 34,763 | 40,608 | 47,654 | 53,957 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 2,720 | 2,277 | 3,533 | 4,021 | 3,509 | 1,475 | |||
| Taxes payable | ✕ | ✕ | ✕ | ✕ | 85 | 56 | ✕ | ||
| Employee-related liabilities | ✕ | ✕ | ✕ | ✕ | 1,186 | 923 | ✕ | ||
| Accounts payable | 804 | 1,172 | 1,585 | 1,158 | 1,079 | 479 | |||
| Accrued liabilities | 1,916 | 1,105 | 1,948 | 1,593 | 1,451 | 996 | |||
| Debt | 23 | 33 | 44 | 68 | 96 | 118 | |||
| Other undisclosed current liabilities | 1,145 | 1,014 | 1,369 | (31) | 130 | 896 | |||
| Total current liabilities: | 3,887 | 3,325 | 4,946 | 4,058 | 3,736 | 2,489 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 390 | 394 | 398 | 3,223 | 3,330 | 3,441 | |||
| Long-term debt, excluding current maturities | 386 | 386 | 386 | 386 | 386 | 386 | |||
| Finance lease, liability | 4 | 8 | 12 | 17 | 26 | 40 | |||
| Liabilities, other than long-term debt | 2,512 | 2,617 | 2,721 | ||||||
| Operating lease, liability | 2,512 | 2,617 | 2,721 | 2,820 | 2,918 | 3,015 | |||
| Other undisclosed noncurrent liabilities | 113 | 106 | 591 | (2,236) | (2,341) | (2,445) | |||
| Total noncurrent liabilities: | 3,015 | 3,117 | 3,709 | 3,807 | 3,907 | 4,011 | |||
| Total liabilities: | 6,903 | 6,442 | 8,656 | 7,865 | 7,643 | 6,500 | |||
| Equity | |||||||||
| Equity, attributable to parent | 21,548 | 27,800 | 26,107 | 32,743 | 40,011 | 47,457 | |||
| Common stock | 0 | 0 | 0 | 0 | 0 | 0 | |||
| Additional paid in capital | 139,570 | 139,292 | 130,119 | 129,808 | 129,449 | 128,713 | |||
| Accumulated deficit | (118,022) | (111,492) | (104,012) | (97,066) | (89,438) | (81,256) | |||
| Total equity: | 21,548 | 27,800 | 26,107 | 32,743 | 40,011 | 47,457 | |||
| TOTAL LIABILITIES AND EQUITY: | 28,451 | 34,242 | 34,763 | 40,608 | 47,654 | 53,957 | |||
Income Statement (P&L) ($ in thousands)Annual | Quarterly
| 9/30/2023 Q3 | 6/30/2023 Q2 | 3/31/2023 Q1 | 12/31/2022 Q4 | 9/30/2022 Q3 | 6/30/2022 Q2 | 3/31/2022 Q1 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 9 | 8 | 930 | 12 | 4 | 7 | ||
| Cost of revenue (Cost of Goods and Services Sold) | (125) | (125) | (125) | (125) | (125) | (125) | ||
| Gross profit: | (116) | (117) | 805 | (113) | (121) | (118) | ||
| Operating expenses | (6,572) | (7,982) | (7,985) | (7,644) | (8,113) | (7,075) | ||
| Operating loss: | (6,688) | (8,099) | (7,180) | (7,756) | (8,234) | (7,193) | ||
| Nonoperating income | 158 | 619 | 128 | 144 | 61 | 1 | ||
| Investment income, nonoperating | 166 | 102 | 128 | 144 | 61 | 1 | ||
| Interest and debt expense | (1) | (1) | (1) | (1) | (1) | (2) | ||
| Loss from continuing operations: | (6,531) | (7,481) | (7,053) | (7,614) | (8,175) | (7,194) | ||
| Loss before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | ✕ | (7,614) | (8,175) | (7,194) | |
| Other undisclosed net income (loss) | 1 | 107 | (10) | |||||
| Net loss: | (6,531) | (7,480) | (6,946) | (7,614) | (8,175) | (7,204) | ||
| Other undisclosed net income (loss) attributable to parent | 1 | (14) | (8) | |||||
| Net loss available to common stockholders, diluted: | (6,530) | (7,480) | (6,946) | (7,628) | (8,182) | (7,204) | ||
Comprehensive Income ($ in thousands)Annual | Quarterly
| 9/30/2023 Q3 | 6/30/2023 Q2 | 3/31/2023 Q1 | 12/31/2022 Q4 | 9/30/2022 Q3 | 6/30/2022 Q2 | 3/31/2022 Q1 | ||
|---|---|---|---|---|---|---|---|---|
| Net loss: | (6,531) | (7,480) | (6,946) | (7,614) | (8,175) | (7,204) | ||
| Comprehensive loss, net of tax, attributable to parent: | (6,531) | (7,480) | (6,946) | (7,614) | (8,175) | (7,204) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.